about
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to targ...
Read More
4.83
0.08
(1.68%)
117.6K
XNAS Volume
High volume today
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Passage Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..